A multicenter phase II study of tgDCC‐E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma - Concepedia

Concepedia

Publication | Closed Access

A multicenter phase II study of tgDCC‐E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma

76

Citations

23

References

2002

Year

Doug Villaret, Bonnie S. Glisson, Daniel E. Kenady, Ehab Y. Hanna, Mary Carey, Lyon L. Gleich, George H. Yoo, Neal D. Futran, Mien‐Chie Hung, Pervin Anklesaria,

Abstract

Intratumoral injections of tgDCC-E1A were safe and well tolerated. Modest tumor response was observed. Further development of tgDCC-E1A is warranted in combination with other treatment modalities.

References

	Year	Citations

Page 1